You are here

Siglion Therapeutics

After First Approval, Experts Point to Barriers in Cell Therapy for Type 1 Diabetes

BioSpace

Thu, 07/13/23 - 10:11 am

type 1 diabetes

Siglion Therapeutics

Biopharma’s green shoots thriving in summer sun as deal activity returns

Fierce Biotech

Tue, 07/11/23 - 11:18 pm

Siglion Therapeutics

DiCE Therapeutics

Sigilon focuses on type 1 diabetes, reduces spend on MPS-1 after letting CMO go

Endpoints

Wed, 03/15/23 - 09:24 pm

Siglion Therapeutics

type 1 diabetes

Sigilon Uncovers Possible Reason Behind Hemophilia A Trial Hold

BioSpace

Tue, 11/30/21 - 10:28 am

Siglion Therapeutics

Sigilon picks up $80M to test hemophilia cell therapy in humans

Fierce Biotech

Sat, 03/21/20 - 02:02 pm

Siglion Therapeutics